Academic expert: Is social media addictive?
Peer-Reviewed Publication
Updates every hour. Last Updated: 13-Jun-2026 04:15 ET (13-Jun-2026 08:15 GMT/UTC)
Duracyte is a biotechnology company developing implantable “living pharmacy” devices designed to continuously produce therapeutic proteins inside the body. The company plans to initiate a Phase 1 clinical trial this year evaluating patients with recurrent ovarian cancer. Duracyte is the third company launched by RBL LLC, following Sentinel BioTherapeutics and SteerBio, reinforcing Houston’s growing role as a biotechnology innovation hub.
A joint research team led by Professor Shiqi (Shawn) Ou, Associate Professor Yahui Jia, and Associate Professor Yuan Lin from South China University of Technology, together with Associate Professor Zhixia Li from the University of Cincinnati, proposed a cross-temporal electric vehicle battery health assessment framework called D2B (Drive-to-Battery), aiming to establish a link between daily driving behavior and long-term battery health.
A study advises against exposing newborns to sunlight through windows to prevent jaundice. The study, involving researchers from the Gandia campus, shows that sunlight entering through windows exceeds phototherapy levels and may pose health risks to the baby.